A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...

Advisers to the FDA will debate if the virus has mutated enough since last winter to require a tweak to the formula.

Two global health groups that fund billions of dollars worth of critical medical aid - from childhood vaccines to malaria ...

Frank DeStefano, MD, MPH, was there when the CDC's Vaccine Safety Datalink (VSD) first came online in 1990, when the agency ...

The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...

A rehab firm will pay a cash settlement to an occupational therapist it fired when the worker declined a COVID-19 vaccination ...

On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine.

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.

FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.

Advisers to the Food and Drug Administration met Thursday to help decide which variant of the virus that causes COVID should ...

The U.S. Food and Drug Administration's advisory panel is set to vote on Thursday to recommend whether COVID-19 vaccines for ...